BriaCell Therapeutics Corp (BCTXW) — Financial Flexibility Index
BriaCell Therapeutics Corp (BCTXW) has a Financial Flexibility Index of -2.41x as of January 2026. Free cash flow of $-8.09 Million (operating CF $-8.09 Million minus capex $0.00) represents -2% of total liabilities ($3.35 Million). Also explore net asset growth rate of BriaCell Therapeutics Corp to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BriaCell Therapeutics Corp Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for BriaCell Therapeutics Corp across 20 annual periods. Check BriaCell Therapeutics Corp PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BriaCell Therapeutics Corp (2006–2025)
Year-by-year free cash flow to debt coverage for BriaCell Therapeutics Corp. For the full company profile including market capitalisation, see BriaCell Therapeutics Corp (BCTXW) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.53x | $-28.17 Million | $-28.17 Million | $4.32 Million | ▼ -136.0% |
| 2024 | -2.77x | $-23.67 Million | $-24.13 Million | $8.56 Million | ▼ -260.4% |
| 2023 | -0.77x | $-23.74 Million | $-23.74 Million | $30.94 Million | ▼ -98.2% |
| 2022 | -0.39x | $-12.48 Million | $-12.48 Million | $32.25 Million | ▲ +96.1% |
| 2021 | -9.90x | $-7.75 Million | $-7.75 Million | $782.24K | ▼ -3123.4% |
| 2020 | -0.31x | $-1.16 Million | $-1.16 Million | $3.77 Million | ▲ +91.6% |
| 2019 | -3.66x | $-3.87 Million | $-3.87 Million | $1.06 Million | ▼ -28.8% |
| 2018 | -2.84x | $-3.81 Million | $-3.81 Million | $1.34 Million | ▼ -63.9% |
| 2017 | -1.73x | $-1.54 Million | $-1.54 Million | $885.90K | ▲ +93.0% |
| 2016 | -24.68x | $-1.20 Million | $-1.20 Million | $48.59K | ▼ -209.7% |
| 2015 | -7.97x | $-933.52K | $-935.26K | $117.17K | ▼ -6563.5% |
| 2014 | -0.12x | $-219.72K | $-363.97K | $1.84 Million | ▼ -112.2% |
| 2013 | 0.98x | $73.24K | $-368.52K | $74.46K | ▼ -86.9% |
| 2012 | 7.49x | $2.13 Million | $-381.49K | $283.94K | ▲ +137.2% |
| 2011 | 3.16x | $1.77 Million | $-690.76K | $559.43K | ▼ -46.5% |
| 2010 | 5.91x | $172.30K | $-309.37K | $29.15K | ▲ +369.8% |
| 2009 | -2.19x | $-140.59K | $-140.59K | $64.19K | ▲ +60.8% |
| 2008 | -5.59x | $-87.41K | $-87.41K | $15.64K | ▲ +39.0% |
| 2007 | -9.16x | $-87.76K | $-87.76K | $9.58K | ▼ -13543.1% |
| 2006 | 0.07x | $1.13K | $1.13K | $16.54K | — |